Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.
Greg Brozeit has been engaged in myeloma patient advocacy since 1998. He began working with the Myeloma Crowd in 2015. Prior to that, he consulted with Dr. Bart Barlogie at the University of Arkansas after working with the International Myeloma Foundation for 15 years, where he inaugurated the public policy advocacy program, patient support group outreach and IMF Europe, organizing more than 100 physician and patient education programs. He earned his BA in political science from Loyola University in New Orleans and lives in northeast Ohio.
Todd Foster is the head of Product at HealthTree, he is an IT healthcare executive who specializes in patient experience and clinical process improvements. Todd was director of Patient and Provider Experience at MD Anderson for over a decade. Prior experience includes leadership of IT development projects at Intermountain HealthCare and United HealthCare. Todd has a passion for using technology that can help patients have a better life and along the way, help to further research for a cure.
Suzanne Lentzsch, MD, PhD, is Professor of Clinical Medicine and the Director of the Multiple Myeloma and Amyloidosis Service at the Columbia University Medical Center in New York. Her translational research focuses on identifying novel targets for the treatment of myeloma, myeloma bone disease, and AL amyloidosis. Dr. Lentzsch is a member of the National Cancer Institute’s Myeloma Steering Committee, the SWOG Myeloma Working Group, co-chairs the International Myeloma Society’s Career Development Committee, and serves as a grant reviewer for the Leukemia and Lymphoma Society and Stand Up 2 Cancer (SU2C) in collaboration with the American Association for Cancer Research. She will begin a four-year term in 2021 on the American Society of Hematology’s Scientific Committee on Plasma Cell Neoplasia and as Associate Editor for the Journal of Clinical Oncology. Prior to joining Columbia University, Dr. Lentzsch served as Clinical Director of the Multiple Myeloma Program at the University of Pittsburgh Cancer Institute (UPCI). She served a research fellowship to study the mechanism of action of thalidomide and its derivatives in multiple myeloma under the mentorship of Dr. Kenneth Anderson at the Dana-Farber Cancer Institute in Boston. She completed a fellowship and residency at the Humboldt University/Charité Berlin, Germany, where she earned her MD.
Ana is an Engineer and a Psychotherapist, she has experience in both fields and loves them equally. She leads the Patient Experience Team at HealthTree and she’s passionate about talking to patients and empowering them. Whenever she’s not working you’ll find her exploring the world, eating different kinds of food, hiking or skiing.
Craig Hofmeister, MD, MPH, is Associate Professor of the Department of Hematology and Medical Oncology at Emory University School of Medicine and the Winship Cancer Institute. His practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. Dr. Hofmeister’s research interests include relapsed myeloma, improving the efficacy of stem cell transplantation, and the development of monoclonal antibodies. He has extensive experience in developing and leading clinical trials in the upfront and relapsed myeloma settings. Dr. Hofmeister was a finalist for the first Myeloma Crowd Research Initiative grants competition for his research in CAR T cell research to target the monoclonal antibody CS 1. He also serves on the steering committee of the Multiple Myeloma Research Consortium (MMRC). Dr. Hofmeister completed his residency and fellowships in hematology/oncology and transplant at the Loyola University Medical Center in Chicago, IL. He earned his medical degree at The Ohio State University College of Medicine in Columbus, OH.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113